BMS 6063 500 (Glucophage XR 500 mg)
Generic Name: metformin
Pill imprint BMS 6063 500 has been identified as Glucophage XR 500 mg.
Glucophage XR is used in the treatment of diabetes, type 2; insulin resistance syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Glucophage XR 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- metformin
- Imprint:
- BMS 6063 500
- Strength:
- 500 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Non-sulfonylureas
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6063
- Inactive Ingredients:
- carboxymethylcellulose sodium
hypromelloses
microcrystalline cellulose
magnesium stearate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66336-0292 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More about Glucophage XR (metformin)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
